Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction

Clinical and Experimental Pharmacology & Physiology
Toshio ImanishiIchiro Nishio

Abstract

1. Recent studies have revealed an association between coronary risk factors and both the number and function of bone marrow-derived endothelial progenitor cells (EPC). We investigated the effect of oxidized low-density lipoprotein (ox-LDL) on the senescence of EPC, leading to cellular dysfunction. 2. Endothelial progenitor cells were isolated from human peripheral blood and characterized. The exposure of cultured EPC to ox-LDL (10 microg/mL) significantly accelerated the rate of senescence compared with control during 20 days in culture as determined by acidic beta-galactosidase staining. Oxidized LDL-induced EPC senescence was significantly inhibited by pretreatment with either lectin-like ox-LDL receptor-1 (LOX-1) antibody (Ab) or atorvastatin (P < 0.01). 3. Because cellular senescence is critically influenced by telomerase, which elongates telomeres, we measured telomerase activity using a polymerase chain reaction-ELISA-based assay. Oxidized LDL significantly diminished telomerase activity to approximately 50%, an effect that was significantly abolished by pretreatment with either LOX-1 Ab or atorvastatin (P < 0.01). 4. We examined whether ox-LDL-induced EPC senescence translates into EPC dysfunction. An MTS assay disclose...Continue Reading

References

Jul 1, 1992·Experimental Gerontology·W E Wright, J W Shay
Aug 1, 1990·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·C W Greider
May 31, 1990·Nature·C B HarleyC W Greider
Mar 1, 1986·The Journal of Clinical Investigation·J W HeineckeA Chait
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·G P DimriO Pereira-Smith
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C KalkaT Asahara
Feb 14, 2003·The New England Journal of Medicine·Jonathan M HillToren Finkel
Aug 28, 2003·Clinical and Experimental Pharmacology & Physiology·Toshio ImanishiIchiro Nishio

❮ Previous
Next ❯

Citations

Mar 1, 2012·Archives of Pharmacal Research·Kyeong-A KimOk-Nam Bae
May 7, 2009·Acta Pharmacologica Sinica·Feng-xia MaZhong-chao Han
Dec 17, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·O J MacEneaneyC A DeSouza
Mar 26, 2010·Journal of Human Hypertension·O J MacEneaneyB L Stauffer
May 13, 2009·Nature Reviews. Rheumatology·Peter E Westerweel, Marianne C Verhaar
Jul 13, 2012·Pediatric Research·Francesca I Fabbri-ArrigoniNigel Klein
Mar 5, 2008·Antioxidants & Redox Signaling·Timothy WatsonGregory Y H Lip
Mar 25, 2009·Antioxidants & Redox Signaling·Masuko Ushio-Fukai, Norifumi Urao
Aug 18, 2010·Antioxidants & Redox Signaling·Felix Fleissner, Thomas Thum
May 23, 2012·International Journal of Vascular Medicine·Gopi Krishna KolluruChristopher G Kevil
Jul 4, 2012·Lipids in Health and Disease·Hui YangSheng-Hua Zhou
Aug 16, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshio ImanishiIchiro Nishio
Jan 20, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshio ImanishiIchiro Nishio
Aug 31, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Katsunobu KobayashiTakashi Akasaka
Feb 6, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·En-Hui YaoKoichi Matsumoto
May 6, 2009·Seminars in Immunopathology·Fabrizio Montecucco, François Mach
Jul 3, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Andrzej ParzonkoMarek Naruszewicz
May 29, 2012·Biochemical and Biophysical Research Communications·Masaaki IwabayashiRyuichi Morishita
Feb 4, 2016·Stem Cells International·Caterina Oriana AragonaGiuseppe Mandraffino
Dec 25, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·George Tsirpanlis
May 12, 2007·Atherosclerosis·Gian Paolo FadiniAngelo Avogaro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.